CY1106198T1 - Γονιδιακη θepαπεια που διαμεσολαβειται απο αδενοϊο - Google Patents

Γονιδιακη θepαπεια που διαμεσολαβειται απο αδενοϊο

Info

Publication number
CY1106198T1
CY1106198T1 CY20061101473T CY061101473T CY1106198T1 CY 1106198 T1 CY1106198 T1 CY 1106198T1 CY 20061101473 T CY20061101473 T CY 20061101473T CY 061101473 T CY061101473 T CY 061101473T CY 1106198 T1 CY1106198 T1 CY 1106198T1
Authority
CY
Cyprus
Prior art keywords
adenoe
gene therapy
mediated gene
adenovirus
useful
Prior art date
Application number
CY20061101473T
Other languages
English (en)
Inventor
Seppo Yla-Herttuala
Anu-Maaria Sandmair
Sami Loimas
Matti Vapalahti
Original Assignee
Ark Therapeutics Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10842035&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1106198(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ark Therapeutics Limited filed Critical Ark Therapeutics Limited
Publication of CY1106198T1 publication Critical patent/CY1106198T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Ένας αδενοϊός που έχει ένα λειτουργικό γονίδιο θυμιδίνης κινάσης είναι χρήσιμος για τη θεραπεία εγκεφαλικών όγκων.
CY20061101473T 1998-11-06 2006-10-13 Γονιδιακη θepαπεια που διαμεσολαβειται απο αδενοϊο CY1106198T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9824437.9A GB9824437D0 (en) 1998-11-06 1998-11-06 Gene therapy
PCT/EP1999/009017 WO2000028059A1 (en) 1998-11-06 1999-11-05 Adenovirus-mediated gene therapy

Publications (1)

Publication Number Publication Date
CY1106198T1 true CY1106198T1 (el) 2011-06-08

Family

ID=10842035

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101473T CY1106198T1 (el) 1998-11-06 2006-10-13 Γονιδιακη θepαπεια που διαμεσολαβειται απο αδενοϊο

Country Status (18)

Country Link
US (1) US6579855B1 (el)
EP (1) EP1135513B2 (el)
JP (1) JP4733833B2 (el)
KR (1) KR20020013473A (el)
CN (1) CN1184321C (el)
AT (1) ATE341639T1 (el)
AU (1) AU749451B2 (el)
CA (1) CA2348624C (el)
CY (1) CY1106198T1 (el)
DE (1) DE69933468T3 (el)
DK (1) DK1135513T4 (el)
ES (1) ES2273521T5 (el)
GB (1) GB9824437D0 (el)
HU (1) HUP0104046A3 (el)
NO (1) NO330776B1 (el)
PL (1) PL193076B1 (el)
PT (1) PT1135513E (el)
WO (1) WO2000028059A1 (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0910950D0 (en) 2009-06-24 2009-08-05 Ark Therapeutics Ltd Filtration
GB0916997D0 (en) * 2009-09-28 2009-11-11 Ark Therapeutics Ltd Combination therapy
US20130296407A1 (en) * 2011-01-18 2013-11-07 Ark Therapeutics, Ltd. Combination Therapy for Cancer
GB201100804D0 (en) * 2011-01-18 2011-03-02 Ark Therapeutics Ltd Drug combination
MX367842B (es) 2012-02-07 2019-09-09 Global Bio Therapeutics Inc Método compartimentado de administración de ácidos nucleicos y composiciones y usos del mismo.
EP2994168A4 (en) * 2013-05-08 2016-10-05 Finvector Vision Therapies Ltd TREATMENT OF HIGH-GRADE GLIOMA OPERABLE BY GENE THERAPY BASED ON SITIMAGEN CÉRADENOVEC AND GANCICLOVIR
ES2733911T3 (es) 2013-08-08 2019-12-03 Global Bio Therapeutics Inc Dispositivo de sujeción para procedimientos minimamente invasivos
DE102019000490A1 (de) 2019-01-23 2020-07-23 HAEMES Verwaltungsgesellschaft mbH Verwendung von Oligonukleotiden für die Behandlung von Tumoren
JP2023510115A (ja) 2019-12-20 2023-03-13 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 新規ｉｌ２アゴニストおよびそれらの使用方法
KR20230009430A (ko) 2020-05-12 2023-01-17 리제너론 파아마슈티컬스, 인크. 신규 il10 효능제 및 그의 사용 방법
CN117597365A (zh) 2021-05-04 2024-02-23 再生元制药公司 多特异性fgf21受体激动剂及其应用
KR20240035845A (ko) 2021-07-19 2024-03-18 리제너론 파아마슈티컬스, 인크. Il12 수용체 효능제 및 그의 사용 방법
AU2022383847A1 (en) 2021-11-11 2024-06-20 Regeneron Pharmaceuticals, Inc. Cd20-pd1 binding molecules and methods of use thereof
US20240247069A1 (en) 2023-01-13 2024-07-25 Regeneron Pharmaceuticals, Inc. Fgfr3 binding molecules and methods of use thereof
WO2024151978A1 (en) 2023-01-13 2024-07-18 Regeneron Pharmaceuticals, Inc. Il12 receptor agonists and methods of use thereof
WO2024182540A2 (en) 2023-02-28 2024-09-06 Regeneron Pharmaceuticals, Inc. T cell activators and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0662441B2 (ja) * 1986-02-18 1994-08-17 花王株式会社 抗腫瘍物質徐放性製剤
US5631236A (en) * 1993-08-26 1997-05-20 Baylor College Of Medicine Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk

Also Published As

Publication number Publication date
DK1135513T4 (da) 2011-11-21
NO20012220L (no) 2001-05-04
JP4733833B2 (ja) 2011-07-27
PT1135513E (pt) 2006-12-29
EP1135513A1 (en) 2001-09-26
AU749451B2 (en) 2002-06-27
AU1385100A (en) 2000-05-29
JP2002529097A (ja) 2002-09-10
GB9824437D0 (en) 1999-01-06
CA2348624A1 (en) 2000-05-18
NO20012220D0 (no) 2001-05-04
EP1135513B2 (en) 2011-08-10
CN1184321C (zh) 2005-01-12
CA2348624C (en) 2012-07-31
NO330776B1 (no) 2011-07-11
DK1135513T3 (da) 2006-11-27
ES2273521T3 (es) 2007-05-01
WO2000028059A1 (en) 2000-05-18
HUP0104046A2 (hu) 2002-01-28
CN1325450A (zh) 2001-12-05
US6579855B1 (en) 2003-06-17
EP1135513B1 (en) 2006-10-04
DE69933468T3 (de) 2012-01-19
PL349489A1 (en) 2002-07-29
PL193076B1 (pl) 2007-01-31
ATE341639T1 (de) 2006-10-15
ES2273521T5 (es) 2011-12-28
KR20020013473A (ko) 2002-02-20
DE69933468D1 (de) 2006-11-16
HUP0104046A3 (en) 2003-09-29
DE69933468T2 (de) 2007-01-11

Similar Documents

Publication Publication Date Title
CY1106198T1 (el) Γονιδιακη θepαπεια που διαμεσολαβειται απο αδενοϊο
NO20005864D0 (no) Quinasoler til behandling av hjernesvulst
ITMI991608A0 (it) Sonda elettrochirurgica per il trattamento di tumori mediante radiofre quenza
EE200200673A (et) Kinasoliini derivaadid kasvajate raviks
BR9603841A (pt) Aparelho para o tratamento hipertérmico de tumores
EE200100603A (et) Inimese refraktaarsete kasvajate ravi epidermaalse kasvufaktori retseptori antagonistidega
BR9608651A (pt) Método para o tratamento de hiperplasia prostática benigna com terapia térmica
DE59810618D1 (de) Hochfrequenzchirurgie-Instrument
AU1939200A (en) Electrochemical treatment of malignant tumors
DE69828110D1 (de) Kapazitiv angekoppelter elektrochirurgischer Trokar
PT1075315E (pt) Iluminador para terapia fotodinamica
FI971568A (fi) Menetelmä resistenttien kasvainten hoitamiseksi
EP0963207A4 (en) GENE THERAPY AGAINST TUMORS BY INTERLEUKIN 12
NO20005885L (no) Kombinasjonsterapi for behandling av refraktær depresjon
AU3552399A (en) Recombinant poliovirus for the treatment of cancer
ITMI962745A0 (it) Sonda-catetere per il trattamento di tumori di organi parenchimatosi con ipertermia interstiziale indotta da radiofrequenza
PT752870E (pt) Utilizacao de mycobacterium para o tratamento de tumores
AU1264200A (en) Use of neoangiogenesis markers for diagnosing and treating tumours by therapy
NO972228D0 (no) Nytt tumorsuppresor-gen, HIC-1
PT907358E (pt) Terapia de distribuicao uniforme de droga
NO20022245D0 (no) Onkolyttiske kombinasjoner for behandling av cancer
DE59510240D1 (de) Hochfrequenztherapieeinrichtung zur interstitiellen Thermotherapie von Tumoren
NO20006047D0 (no) Fremgangsmåte for genterapi
CY1106194T1 (el) Θepαπευτικη αγωγη της δυσκινησιας
HK1047048A1 (en) Therapeutic use of melatonin.